Dogwood Therapeutics Inc.
DWTX | NASDAQ
$1.63
-$0.06 (-3.55%)
At close: Sep 21, 2026, 3:59 PM ET
$1.76
+$0.13 (+7.98%)
Pre-market:
Sep 22, 2026, 8:46 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -27.97M | -12.23M | -5.45M | -12.32M | -15.64M | -10.01M |
Interest Income | 96.94K | n/a | 150.9K | 67.48K | 5.67K | n/a |
Pretax Income | -34.04M | -12.35M | -5.3M | -12.25M | -15.96M | -10.35M |
Net Income | -34.26M | -12.35M | -5.3M | -12.25M | -15.96M | -10.35M |
Selling & General & Admin | 6.1M | 8.7M | 3.72M | 4.25M | 4.85M | 9.81M |
Research & Development | 21.87M | 3.53M | 1.73M | 8.07M | 10.8M | 194.01K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 27.97M | 12.23M | 5.45M | 12.32M | 15.64M | 10.01M |
Interest Expense | n/a | 92.19K | n/a | n/a | n/a | 384.22K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 27.97M | 12.23M | 5.45M | 12.32M | 15.64M | 10.01M |
Income Tax Expense | 221.1K | -503 | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 8.22M | 1.03M | 751.07K | 442.8K | 333.17K | 197.08K |
Shares Outstanding (Diluted) | 8.22M | 1.03M | 751.07K | 442.8K | 333.17K | 197.08K |
EPS (Basic) | -4.32 | -12.52 | -7.05 | -27.66 | -47.90 | -52.50 |
EPS (Diluted) | -4.32 | -12.52 | -7.05 | -27.66 | -47.90 | -52.50 |
EBITDA | -34.03M | -12.25M | -5.3M | -12.25M | -15.96M | -10.01M |
EBIT | -34.04M | -12.26M | -5.3M | -12.25M | -15.96M | -10.01M |
Depreciation & Amortization | 2.06K | 12.18K | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DWTX